Latest news, updates, and announcements from DeepCyte.
DeepCyte announced a $1.5 M seed round to launch its AI-driven single‑cell toxicology platform, MetaCore, aimed at predicting drug safety at the cellular level. This early‑stage capital will accelerat...
